According to the available information, the patient's legal representative reported pain, chronic uti, vaginal bleeding, urinary incontinence, vaginal discharge, mesh erosion.Restorelle l was implanted on (b)(6) 2016 and excised on (b)(6) 2016.Corrective action: management routinely reviews events such as this and monitors complaint levels.Additionally, events of this type relating to the reported complaints are captured in the product risk documentation.Based on this, and because the device is not available for evaluation, no further corrective action is required at this time.Coloplast has not been provided any corroborating evidence to verify the information contained in this report.Device not returned.
|
As reported to coloplast, though not verified, patient's legal representative reported pain, chronic uti, vaginal bleeding, urinary incontinence, vaginal discharge, mesh erosion.Additional information received on 04/09/2021.Palpable mesh, overactive bladder, cystocele.(b)(6) 2016 - chronic uti after anterior repair.(b)(6) 2016 - eroded mesh.Cystourethroscopy with sounding, pelvic exam, excision of eroded vaginal mesh.Small exposed mesh vs suture, vaginal burning/pain.(b)(6) 2016 - cystourethroscopy with sound pelvic, mesh excision.(b)(6) 2016 - erosion.Laser ablation of eroded mesh and excision with closure of the vaginal mucosa with vaginoscopy and cystoscopy.Abdominal pain, fever, vaginal discharge, positive blood cultures.Exposure, grade 1 rectocele and cystocele, granulation tissue, tender right proximal limb.(b)(6) 2016 - chronic inflammation and necrotic tissue with mesh graft exposure in the left anterior vaginal wall and painful right proximal graft limb with palpable anchor.Excision of necrotic vaginal wall tissue and mesh graft material.Patch graft with a-cell graft and excision of bone anchor.Infected mesh.No other adverse patient effects were reported.
|